Cardiovascular Drugs Practice Questions

Q: Beta-blockers are contraindicated in which of the following conditions?

Sick sinus syndrome. **Explanation:** **Why Sick Sinus Syndrome (SSS) is the correct answer:** Beta-blockers are competitive antagonists at $\beta_1$-adrenergic receptors in the heart. Their primary electrophysiological effects include a decrease in the firing rate of the SA node (negative chronotropy) and a decrease in conduction velocity through the AV node (negative dromotropy). In **Sick Sinus Syndrome**, the SA node is already dysfunctional, leading to episodes of severe bradycardia or sinus arrest. Administering beta-blockers in this condition can dangerously exacerbate bradycardia or lead to complete heart block, making it a **strict contraindication**. **Why the other options are incorrect:** * **Angina Pectoris:** Beta-blockers are first-line agents. They reduce myocardial oxygen demand by lowering heart rate and contractility, thereby preventing ischemic episodes. * **Acute Aortic Dissection:** They are essential in management (often IV Esmolol or Labetalol) to reduce the "shear stress" ($dP/dt$) on the aortic wall by lowering both heart rate and blood pressure. * **Post Myocardial Infarction:** Beta-blockers are "cardioprotective." they reduce the risk of re-infarction, limit infarct size, and prevent post-MI arrhythmias and ventricular remodeling. **High-Yield Clinical Pearls for NEET-PG:** * **Other Contraindications:** Overt heart failure (acute decompensation), 2nd or 3rd-degree heart block, and severe bronchial asthma. * **Prinzmetal Angina:** Beta-blockers are contraindicated here as they can cause unopposed $\alpha$-mediated coronary vasoconstriction. * **Diabetes:** Use with caution as they can mask the tachycardic symptoms of hypoglycemia. * **Drug of Choice:** Esmolol is the shortest-acting beta-blocker (half-life ~9 mins), preferred for intraoperative hypertensive crises.

Q: Which PFOR inhibitor is used in the management of angina?

Trimetazidine. **Explanation:** **Trimetazidine** is the correct answer because it is a metabolic modulator that acts as a **Partial Fatty Acid Oxidation (p-FOX) inhibitor**. **Mechanism of Action:** Under normal conditions, the heart derives energy primarily from fatty acid oxidation. However, this process requires more oxygen per unit of ATP produced compared to glucose oxidation. Trimetazidine inhibits the enzyme **3-ketoacyl-CoA thiolase**, shifting the myocardial metabolism from fatty acid oxidation to **glucose oxidation**. This shift improves the efficiency of oxygen utilization, maintaining ATP production even under ischemic conditions without affecting heart rate or blood pressure. **Analysis of Incorrect Options:** * **A. Nifedipine:** A dihydropyridine Calcium Channel Blocker (CCB). It acts by causing peripheral vasodilation and coronary artery dilation, reducing afterload. It does not inhibit p-FOX. * **C. Atenolol:** A cardioselective $\beta_1$-blocker. It manages angina by reducing myocardial oxygen demand through a decrease in heart rate and contractility. * **D. Fasudil:** A **Rho-kinase inhibitor**. It is primarily used in the management of cerebral vasospasm following subarachnoid hemorrhage and is being studied for pulmonary hypertension, but it is not a p-FOX inhibitor. **High-Yield Clinical Pearls for NEET-PG:** * **Trimetazidine** is used as an add-on therapy for stable angina when first-line drugs are insufficient or not tolerated. * **Side Effects:** It can cause **Parkinsonian symptoms** (tremors, rigidity), gait disturbances, and restless leg syndrome, especially in elderly patients. * **Ranolazine** is another metabolic modulator used in angina; it acts by inhibiting the **late sodium current ($I_{Na}$)**, reducing calcium overload in ischemic myocytes.

Q: Which of the following antihypertensives causes sedation?

Clonidine. **Explanation:** **Correct Answer: A. Clonidine** Clonidine is a centrally acting **$\alpha_2$-adrenergic agonist**. It stimulates $\alpha_2$ receptors in the nucleus tractus solitarius (NTS) of the medulla, leading to a decrease in sympathetic outflow from the vasomotor center. This reduction in sympathetic tone results in bradycardia and vasodilation. Because it crosses the blood-brain barrier and inhibits the release of norepinephrine in the CNS, it commonly causes **sedation** and mental depression. This "central effect" is a classic side effect frequently tested in exams. **Why the other options are incorrect:** * **B. Hydralazine:** A direct-acting vasodilator that primarily affects arterioles. Its common side effects include reflex tachycardia, fluid retention, and a Lupus-like syndrome, but not sedation. * **C. Losartan:** An Angiotensin II Receptor Blocker (ARB). It is generally well-tolerated; its most notable feature is the lack of cough (unlike ACE inhibitors). It does not cross the blood-brain barrier significantly to cause sedation. * **D. Amlodipine:** A Dihydropyridine Calcium Channel Blocker (CCB). Its primary side effects are peripheral edema, headache, and flushing due to potent peripheral vasodilation. **High-Yield Clinical Pearls for NEET-PG:** * **Rebound Hypertension:** Abrupt withdrawal of Clonidine can cause a hypertensive crisis due to a sudden surge in catecholamines. * **Other uses:** Clonidine is also used in opioid withdrawal, ADHD, and prophylaxis for migraine. * **Methyldopa:** Another centrally acting $\alpha_2$ agonist used in pregnancy-induced hypertension; it also causes sedation and a positive Coombs test.

Q: Which antihypertensive medication can be safely used in patients with gout and diabetes mellitus?

Enalapril. **Explanation:** The correct answer is **Enalapril (Option B)**. **Why Enalapril is correct:** Enalapril is an ACE inhibitor (ACEi). In patients with **Diabetes Mellitus**, ACE inhibitors are the drugs of choice because they provide **renoprotection** by dilating the efferent arteriole, thereby reducing intraglomerular pressure and slowing the progression of diabetic nephropathy. Regarding **Gout**, ACE inhibitors are metabolic neutral; they do not increase serum uric acid levels. In fact, some drugs in this class (like Losartan) have uricosuric properties, making them ideal for patients with hyperuricemia. **Why other options are incorrect:** * **Thiazides (Option A):** These are contraindicated or used with caution in both conditions. They cause **hyperuricemia** (by competing with uric acid for secretion in the proximal tubule) and **hyperglycemia** (by inhibiting insulin release and reducing peripheral glucose utilization). * **Propranolol (Option C):** This is a non-selective beta-blocker. It can mask the warning symptoms of hypoglycemia (tachycardia) in diabetics and may worsen peripheral vascular disease. It also tends to decrease urate excretion. * **Diazoxide (Option D):** This is a potent vasodilator used in hypertensive emergencies, but it is a known **K+ channel opener** that inhibits insulin release, leading to significant hyperglycemia. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of choice for HTN with Diabetes:** ACE inhibitors or ARBs (due to nephroprotective effects). * **Losartan** is the only ARB that significantly increases uric acid excretion (uricosuric), making it the best choice for HTN with Gout. * **Diuretics to avoid in Gout:** Thiazides and Loop diuretics (both cause hyperuricemia). * **Metabolic side effects of Thiazides:** Remember the "4 Hypers" (Hyperglycemia, Hyperuricemia, Hyperlipidemia, Hypercalcemia) and "3 Hypos" (Hypokalemia, Hyponatremia, Hypomagnesemia).

Q: In a patient with chronic congestive cardiac failure, which of the following drugs does NOT prolong survival?

Digoxin. In chronic Congestive Cardiac Failure (CCF), the primary goal of therapy is to counteract the maladaptive neurohormonal activation (RAAS and Sympathetic Nervous System) that leads to cardiac remodeling and disease progression. **Why Digoxin is the correct answer:** Digoxin is a cardiac glycoside that inhibits the Na+/K+-ATPase pump, increasing intracellular calcium and providing a positive inotropic effect. While it improves symptoms, increases exercise tolerance, and **reduces the rate of hospitalization**, the landmark **DIG Trial** proved that it has **no effect on mortality** (it does not prolong survival). It is now primarily used for symptomatic relief or rate control in patients with concomitant Atrial Fibrillation. **Why the other options are incorrect:** * **Metoprolol & Carvedilol (Beta-blockers):** These drugs reduce the toxic effects of chronic catecholamine exposure. They decrease heart rate, reduce remodeling, and are proven to significantly reduce mortality in stable heart failure (NYHA Class II-IV). Note: Metoprolol must be in the **succinate** (extended-release) form to show mortality benefits. * **Enalapril (ACE Inhibitor):** ACE inhibitors are the cornerstone of CCF therapy. By inhibiting Angiotensin II production, they prevent cardiac remodeling and fibrosis. Large trials (like SOLVD and CONSENSUS) established their role in prolonging survival. **High-Yield Clinical Pearls for NEET-PG:** * **Drugs that reduce mortality in CCF:** ACE inhibitors, ARBs, Beta-blockers (Carvedilol, Metoprolol succinate, Bisoprolol), Aldosterone antagonists (Spironolactone, Eplerenone), ARNI (Sacubitril/Valsartan), and SGLT2 inhibitors (Dapagliflozin). * **Drugs that only improve symptoms (No mortality benefit):** Digoxin, Furosemide (Diuretics), and Dobutamine. * **Digoxin Toxicity:** Characterized by xanthopsia (yellow vision) and various arrhythmias, most commonly **PVCs**; the most specific is **Atrial Tachycardia with AV block**.

Q: A 33-year-old man diagnosed with essential hypertension is started on a blood pressure medication. After 6 weeks, he notes fatigue, rash over his face, joint aches, and effusions. A serum antinuclear antibody (ANA) test is positive. What is the most likely offending agent?

Hydralazine. ### Explanation **Correct Option: D. Hydralazine** The clinical presentation describes **Drug-Induced Lupus Erythematosus (DILE)**. The patient exhibits classic symptoms: constitutional symptoms (fatigue), malar-like rash, arthralgia (joint aches), and serositis (effusions), coupled with a positive ANA test. **Mechanism:** Hydralazine is a direct-acting vasodilator used in hypertension. It is metabolized via **Phase II acetylation** by the enzyme N-acetyltransferase. "Slow acetylators" are at a significantly higher risk of developing DILE because the drug remains in the system longer, leading to the formation of reactive metabolites that trigger an autoimmune response. **Analysis of Incorrect Options:** * **A. Propranolol:** A beta-blocker commonly used for hypertension and prophylaxis of migraine. It does not typically cause autoimmune reactions or DILE. * **B. Nifedipine:** A calcium channel blocker. Common side effects include peripheral edema, flushing, and gingival hyperplasia, but not lupus-like syndromes. * **C. Thiazide Diuretics:** These can cause photosensitivity rashes and metabolic derangements (hyperuricemia, hyperglycemia), but they are not associated with ANA positivity or DILE. **High-Yield NEET-PG Pearls:** 1. **Most Common Drugs causing DILE:** Remember the mnemonic **"SHIPP"**: **S**ulfonamides, **H**ydralazine, **I**soniazid, **P**rocainamide, and **P**henytoin. 2. **Specific Marker:** While ANA is sensitive, **Anti-histone antibodies** are the highly specific hallmark for DILE (present in >90% of cases). 3. **Key Difference:** Unlike Systemic Lupus Erythematosus (SLE), DILE rarely involves the CNS or Kidneys, and symptoms usually resolve upon drug discontinuation. 4. **Procainamide** carries the highest *risk* of inducing DILE, but **Hydralazine** is a more common clinical cause due to its frequent use in heart failure and pregnancy-induced hypertension.

Q: What is the drug of choice for ventricular arrhythmia due to myocardial infarction?

Lidocaine. **Explanation:** **Lidocaine (Option C)** is the drug of choice for treating acute ventricular arrhythmias (VT/VF) specifically occurring in the setting of **Myocardial Infarction (MI)**. As a Class IB anti-arrhythmic, it works by blocking voltage-gated sodium channels. Its unique clinical utility lies in its high affinity for channels in the **depolarized/ischemic state**. In the acidic and hypoxic environment of an MI, lidocaine binds rapidly to inactivated channels, effectively suppressing ectopic foci in the ischemic zone while having minimal effect on normal, healthy myocardial tissue. **Why other options are incorrect:** * **Quinidine (Option A):** A Class IA agent that prolongs the QT interval. It is contraindicated in MI because it can increase mortality and predispose patients to *Torsades de Pointes*. * **Amiodarone (Option B):** While it is the drug of choice for hemodynamically unstable VT/VF in general Advanced Cardiovascular Life Support (ACLS), Lidocaine remains the classic "textbook" answer for arrhythmias specifically triggered by acute ischemia/MI due to its tissue-specific action. * **Phenytoin (Option D):** A Class IB agent primarily used for **Digitalis-induced arrhythmias**, not for routine post-MI management. **High-Yield Pearls for NEET-PG:** * **Route:** Lidocaine must be given **IV** due to extensive first-pass metabolism. * **Toxicity:** Overdose leads to CNS side effects, most notably **seizures**. * **Prophylaxis:** Prophylactic use of Lidocaine in MI is **not recommended** as it may increase the risk of asystole; it is only used for active arrhythmia management. * **Mexiletine** is the orally active analog of Lidocaine.

Question 1

Beta-blockers are contraindicated in which of the following conditions?

Accepted Answer

Sick sinus syndrome

Answer

Angina pectoris

Answer

Acute aortic dissection

Answer

Post myocardial infarction

Question 2

Which PFOR inhibitor is used in the management of angina?

Accepted Answer

Trimetazidine

Answer

Nifedipine

Answer

Atenolol

Answer

Fasudil

Question 3

Which of the following antihypertensives causes sedation?

Accepted Answer

Clonidine

Answer

Hydralazine

Answer

Losartan

Answer

Amlodipine

Question 4

Which antihypertensive medication can be safely used in patients with gout and diabetes mellitus?

Accepted Answer

Enalapril

Answer

Thiazide

Answer

Propranolol

Answer

Diazoxide

Question 5

In a patient with chronic congestive cardiac failure, which of the following drugs does NOT prolong survival?

Accepted Answer

Digoxin

Answer

Metoprolol

Answer

Carvedilol

Answer

Enalapril

Question 6

Which of the following statements regarding antiarrhythmic drugs is FALSE?

Accepted Answer

Verapamil is classified as a Class IV antiarrhythmic.

Answer

Verapamil is contraindicated in sick sinus syndrome.

Answer

Verapamil is contraindicated in complete heart block.

Answer

Verapamil can depress heart rate.

Question 7

A 33-year-old man diagnosed with essential hypertension is started on a blood pressure medication. After 6 weeks, he notes fatigue, rash over his face, joint aches, and effusions. A serum antinuclear antibody (ANA) test is positive. What is the most likely offending agent?

Accepted Answer

Hydralazine

Answer

Propranolol

Answer

Nifedipine

Answer

Thiazide diuretic

Question 8

What is the drug of choice for ventricular arrhythmia due to myocardial infarction?

Accepted Answer

Lidocaine

Answer

Quinidine

Answer

Amiodarone

Answer

Phenytoin

Question 9

Which of the following drugs used to treat glaucoma is contraindicated in patients with urine retention?

Accepted Answer

Disopyramide

Answer

Flecainide

Answer

Lidocaine

Answer

Tocainide

Question 10

What is the mechanism by which aspirin is used for ischemic heart disease?

Accepted Answer

Inhibition of TXA2 synthesis

Answer

Inhibition of prostacyclin synthesis

Answer

Inhibition of COX 2

Answer

Inhibition of endothelin synthesis

Cardiovascular Drugs — MCQs

Cardiovascular Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?